Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.
Mustafa AtmacaBora GulhanEmine KorkmazMihriban InozuOguz SoylemezogluCengiz CandanAysun Karabay BayazıtAhmet Midhat ElmacıGonul ParmaksizAli DuzovaNesrin BesbasRezan TopalogluFatih OzaltinPublished in: Pediatric nephrology (Berlin, Germany) (2017)
ADCK4 mutations are one of the most common causes of adolescent-onset albuminuria and/or CKD of unknown etiology in Turkey. CoQ10 supplementation appears efficacious at reducing proteinuria, and may thereby be renoprotective.